News

Participation in the ¥7 Billion “Mitsui Link Fund” as a Scientific Collaborator – Guiding Science-Backed Investments and Commercialization through Deep Scientific Rigor –

TOKYO, Japan, August 31, 2026 – RealizeEdge Partners Co., Ltd. (Head Office: Chuo-ku, Tokyo; President & CEO: Yoshitsugu Shitaka, Ph.D.; "RealizeEdge Partners") is pleased to announce its participation as a scientific collaborator in the "Mitsui Link Fund," a ¥7 billion life science-focused corporate venture capital (CVC) fund jointly established by Mitsui Fudosan Co., Ltd. (Head Office: Chuo-ku, Tokyo; President and CEO: Takashi Ueda; "Mitsui Fudosan") and Axil Capital Orb I LLP. (Head Office: Minato-ku, Tokyo; Managing Partner: Frederick Shane; "Axil Capital").

The Mitsui Link Fund is dedicated to investing in startups across all growth stages—from seed to later-stage—with a primary focus on drug discovery, medical devices, and health tech.

In the life science sector, where R&D cycles are extensive and capital requirements scale significantly with each growth stage, practical, hands-on support beyond financial investment is essential for nurturing successful startups. As a scientific collaborator, RealizeEdge Partners will provide its accumulated expertise in evaluating and cultivating early-stage drug discovery assets, alongside comprehensive commercialization support. By combining our scientific capabilities with Axil Capital's investment acumen and Mitsui Fudosan's business development network, we will deliver seamless, end-to-end support to accelerate the creation and growth of promising startups.

About Mitsui Fudosan

Mitsui Fudosan is one of Japan’s leading real estate developers, creating mixed-use neighborhoods integrating offices, retail, logistics, hotels, and residences. With a long-term perspective, it enhances urban value. In recent years, the company has evolved beyond traditional real estate into an “industry developer,” fostering new industries through innovation and cross-sector partnerships.

Website: https://www.mitsuifudosan.co.jp/english/

About Axil Capital Group

Axil Capital Group is a Tokyo-based venture capital firm specializing in biomedical and healthcare technologies, creating value across the global life sciences venture ecosystem through strategic alliances worldwide.

Website: https://www.axilcapital.com/company-en

About RealizeEdge Partners

RealizeEdge Partners is a Tokyo-based startup studio established in April 2025. We support innovators with breakthrough ideas to accelerate the creation of drug discovery startups transforming health and brightening lives by integrating scientific excellence with strategic and operational support.

Website: https://realizeedge.com/en/